Global Blood Therapeutics (GBT) Declines; Doctors on Cowen Panel Said Skeptical on GBT440 Mechanism - Bloomberg
- Wall St. rises amid robust earnings, GDP data
- FBI to review more emails related to Clinton's private email use: letter
- Unusual 11 Mid-Day Movers 10/28: (GRVY) (VRTS) (ITGR) Higher; (OPXA) (SNMX) (STON) Lower
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Global Blood Therapeutics (NASDAQ: GBT) Declines; Doctors on Cowen Panel Said Skeptical on GBT440 Mechanism - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Blood Therapeutics' (GBT) Trial Design Raises Unanswered Questions - Bloomberg, Citing Favus
- Stocks with call price movement; VALE TSLA
- Stocks with call price movement; USO BABA
Create E-mail Alert Related CategoriesTrader Talk
Related EntitiesCowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!